Correction to: Ritlecitinib: First Approval

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
1 Online-Ressource.
Sprache
Englisch

Erschienen in
Correction to: Ritlecitinib: First Approval ; volume:83 ; number:15 ; day:5 ; month:10 ; year:2023 ; pages:1457 ; date:10.2023
Drugs ; 83, Heft 15 (5.10.2023), 1457, 10.2023

Klassifikation
Recht

Urheber
Blair, Hannah A.
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1007/s40265-023-01956-8
URN
urn:nbn:de:101:1-2024010809023900984380
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:21 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Blair, Hannah A.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Correction to: Lonafarnib: First Approval

Correction to: Lonafarnib: First Approval

Correction to: Pexidartinib: First Approval

Correction to: Pexidartinib: First Approval

Correction to: Nedosiran: First Approval

Correction to: Nedosiran: First Approval

Correction to: Lenacapavir: First Approval

Correction to: Lenacapavir: First Approval

Correction to: Zavegepant: First Approval

Correction to: Zavegepant: First Approval

Correction to: Spesolimab: First Approval

Correction to: Spesolimab: First Approval

Correction to: Sparsentan: First Approval

Correction to: Sparsentan: First Approval

Correction to: Filgotinib: First Approval

Correction to: Filgotinib: First Approval

Correction to: Ubrogepant: First Approval

Correction to: Ubrogepant: First Approval

Correction to: Triheptanoin: First Approval

Correction to: Triheptanoin: First Approval

Correction to: Selpercatinib: First Approval

Correction to: Selpercatinib: First Approval

Correction to: Daridorexant: First Approval

Correction to: Daridorexant: First Approval

Verbundene Objekte